Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Naprosyn Pain Relief 250 mg Gastro-resistant tablet - UK EMC Drug Approval Details

Approvals/UK EMC/Naprosyn Pain Relief 250 mg Gastro-resistant tablet

Approved

STANDARD

Naprosyn Pain Relief 250 mg Gastro-resistant tablet

Maxwellia Limited🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: df4c497dfc1126d6
Company: Maxwellia Limited
Type: Standard

Approval Details

Approval Id: df4c497dfc1126d6
Drug Approval Emc Name: Naprosyn Pain Relief 250 mg Gastro-resistant tablet
Drug Name: Naprosyn Pain Relief 250 mg Gastro-resistant tablet
Company Name: Maxwellia Limited
Company Address: Alderley Park, Alderley Edge, Cheshire, SK10 4TG, UK
Company Medical Info Direct Line: 01625 315072
Company Medical Info Email: med.info@maxwellia.com
Company Customer Care Direct Line: 01625 315072
Atc Code: M01AE02
Legal Category: Pharmacy

Active Ingredients

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

df4c497dfc1126d6

Type

Standard

Back to UK EMC Approvals